NEJM Infectious Diseases RSS

Dr. Paul Sax takes stock of the ID world, citing some things he's grateful for — an annual tradition in HIV and ID Observations.

This randomized trial showed no difference in local or systemic side effects in patients receiving their vaccines on either schedule.

Combined analysis of two randomized trials showed that levofloxacin prevented development of disease in people exposed to multidrug-resistant tuberculosis.

In a mouse model, PET/MRI demonstrated increased uptake of [18F]-fluorodeoxyglucose–labeled p-aminobenzoic acid at the infected cardiac site.

The editors present their choice of the most important articles from the year.

Multiple autoimmune diseases developed more often among people who had COVID-19 than among those who did not.

Dr. Paul Sax shares 10 facts about a common gastrointestinal infection in HIV and ID Observations.

Although rates of bacterial STIs have largely stabilized, case counts remain high.

In two different studies, rollout of doxyPEP yielded reductions of 50%–80% in incidence of chlamydia and syphilis.

In persons living with HIV who did not respond to prior vaccination, seroprotection was higher with a CpG-adjuvanted vaccine than with an alum-adjuvanted vaccine.